Table 1.
The association between UCHL1 expression and clinical pathologic characteristics in 54 patients with BC.
| Clinical pathologic characteristics | Case No. | UCHL1 expression | p | ||
|---|---|---|---|---|---|
| low | high | ||||
| Total cases | 54 | 31 | 23 | ||
| Age (years) | |||||
| <60 | 25 | 12 | 13 | 0.1943 | |
| ≥60 | 29 | 19 | 10 | ||
| Grade | |||||
| I~II | 21 | 13 | 8 | 0.8150 | |
| III | 29 | 17 | 12 | ||
| unknown | 4 | 1 | 3 | ||
| Regional lymph node invasion | |||||
| N0~N1 | 32 | 21 | 11 | 0.0703 | |
| N2~N3 | 20 | 8 | 12 | ||
| Nx | 2 | 2 | 0 | ||
| Chemotherapeutics (DOX-based) |
|||||
| Chemosensitive | 37 | 25 | 12 | 0.0259* | |
| Chemoresistant | 17 | 6 | 11 | ||
Analysis by χ2 test or Fisher’s exact test, *p < 0.05 value is set for highly significant difference.